SMARCB1 and Ewing sarcoma: DOX concentrations were adjusted to achieve SYBR/TaqMan‐qPCR‐controlled SMARCB1 levels comparable to SMARCB1‐proficient Ewing sarcoma (EwS) cell lines, minimizing experimental artefacts associated with supraphysiological expression (Supplementary Figure S1A‐B).